CORRIGAN MARK 4
4 · Nabriva Therapeutics plc · Filed Jul 30, 2021
Insider Transaction Report
Form 4
CORRIGAN MARK
Director
Transactions
- Award
Share Options
2021-07-28−35,000→ 35,000 totalExercise: $1.08Exp: 2031-07-27→ Ordinary Shares (35,000 underlying) - Award
Ordinary Shares
2021-07-28+17,500→ 17,500 total
Footnotes (3)
- [F1]The reported transaction involved the reporting person's receipt of a grant of 17,500 restricted stock units. The total reported in Column 5 includes the 17,500 newly awarded restricted stock units.
- [F2]The option was granted on July 28, 2021.
- [F3]One hundred percent (100%) of the option will vest on July 31, 2022, subject to the reporting person's continued service on the board of directors of Nabriva Therapeutics plc.